Financials
Financial year 2025
PHARMACIE D'ANDENELLE from Andenne, company number BE0426572643, closed financial year 2025 with a result of € -48,277 after tax. For that financial year PHARMACIE D'ANDENELLE recorded a gross margin of € 101,294 and equity of € 153,459. Compared with financial year 2024, the result moved from € 672 to € -48,277. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ 153,459
▼ 24% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -48,277
▼ still € 672 profit in 2024
Profit after tax over the fiscal year.
€ 87,345
▲ 28% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 91,459.
People and assets in 2025
1.9
▲ 0.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 95,332
▲ 117% vs 2024
€ 50,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 454,826
▲ 12% vs 2024
€ 15,147 is repaid this year. At this pace the long-term loan is gone in ≈ 28 years.
€ 63,938
▲ 29% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 2,378
▼ 63% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 187,572 | € 92,018 | € 81,444 | € 101,294 | ▲ 24% |
| Profit after taxes | € 63,864 | € 15,067 | € 672 | € -48,277 | ▼ € 48,949 |
| Equity | € 185,998 | € 201,065 | € 201,736 | € 153,459 | ▼ 24% |
| Total debts | € 333,561 | € 260,158 | € 460,539 | € 521,964 | ▲ 13% |
| Cash | € 131,706 | € 54,328 | € 68,271 | € 87,345 | ▲ 28% |
| Land & buildings | € 194,515 | € 184,177 | € 173,840 | € 163,502 | ▼ 6% |
| Retained profit | € 123,998 | € 139,065 | € 139,736 | € 91,459 | ▼ 35% |
| Dividend | € 65,000 | € 0 | € 0 | € 0 | |
| Bank debt | € 196,410 | € 187,394 | € 404,530 | € 454,826 | ▲ 12% |
| Balance sheet total | € 519,559 | € 461,222 | € 662,275 | € 675,423 | ▲ 2% |
| Employees (FTE) | 1.5 | 1.4 | 1.4 | 1.9 | ▲ 0.5 |
Key figures of PHARMACIE D'ANDENELLE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE D'ANDENELLE?
What happened at PHARMACIE D'ANDENELLE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 48,277 (▼ € 48,949 vs 2024). Source: NBB ↗
- ASMAE ABIDA stepped down as director. NBB
- AD PHARMA SRL stepped down as director. NBB
- ASMAE ABIDA became a director. NBB
- AD PHARMA SRL became a director. NBB
- New establishment in Andenne. KBO
- Start of the company according to the CBE. KBO
In short
From € 63,864 profit in 2022 to € 48,277 loss in 2025.
Paid € 28,357 in corporate taxes since 2022.
Best year ever: 2022, with € 63,864 profit.
On average € 53,300 of value added per employee in 2025.
A new publication or filing at PHARMACIE D'ANDENELLE? We notify you, reason included.
Follow PHARMACIE D'ANDENELLEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of AD PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE D'ANDENELLEThe shares are held by AD PHARMA (100%).
Directors
According to the 2025 annual accounts
ASMAE ABIDA
Director
since 2019 · until 2025
Managing director · represented by CHRISTOPHE DIMITRI
Also active at: PHARMACIE DU PERRON
since 2019 · until 2025
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Avenue Roi Albert 240
5300 Andenne
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
HETZNER-AS, DE
Website info
Features
Security
Network
Details
- Company number
- 0426.572.643
- VAT number
- BE 0426.572.643
- Registered office
- Avenue Roi Albert 240, 5300 Andenne
- Names & denominations
- PHARMACIE D'ANDENELLE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 17 December 1984
- Peppol
- Active · Active since 8 Jul 2024
- Contact
- pharmacieandenelle.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten